← Eichor
Study identifier: NCT07512700 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Venetoclax Combined With CACAG Regimen Versus "3+7" Regimen in the Treatment of Acute Monocytic Leukemia

Condition: Acute Monocytic Leukemia  ·  Sponsor: Chinese PLA General Hospital

PhasePhase 2
Planned participants204
Who can joinAll sexes, 14 Years to 60 Years
Healthy volunteersNo

About this study

This study is a multicenter, randomized, prospective Phase II clinical trial designed to compare the effectiveness of two treatment approaches for patients with acute monocytic leukemia.

This description comes directly from the study's public registry record.

Talk to the study team

Liping Dou, Doctor  ·  +8613681207138  ·  lipingruirui@163.com

Daihong Liu, Doctor  ·  +8613681171597  ·  daihongrm@163.com

Always discuss trial participation with your own doctor first.

Locations (3)

Air Force Medical Center, PLABeijing, ChinaRecruiting
Chinese PLA General HospitalBeijing, ChinaRecruiting
PLA Strategic Support Force's Characteristic Medical CenterBeijing, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07512700